A Novel Nasal Therapy for Cervical Cancer:
Development of a Cationic Nanogel-based Nasal Therapeutic HPV Vaccine

Chiba University Hospital

Rika NAKAHASHI

Associate ProfessorBased on fundamental research in mucosal immunology, I am developing mucosal vaccines that can be administered via the nasal and oral routes. Through the COVID-19 pandemic, I strongly recognized the importance not only of “not becoming infected,” but also of “not transmitting infection to others.” With the goal of realizing practical mucosal vaccines that can block infection at its entry point, I am actively collaborating with many researchers and industry partners.

Recent Topics of Interests:
Mucosal vaccines, Cancer immunotherapy
Motto in Research or in Life:
Supple in strength, subtle in wisdom
Hobby / Holiday:
Driving and Traveling